Redirecting to original paper in 30 seconds...

Click below to go immediately or wait for automatic redirect

arxiv_ml 50% Match Research Paper Computational biologists,Protein engineers,Bioinformaticians,Researchers in drug discovery 3 weeks ago

PRISM: Enhancing Protein Inverse Folding through Fine-Grained Retrieval on Structure-Sequence Multimodal Representations

generative-ai › autoregressive
📄 Abstract

Abstract: Designing protein sequences that fold into a target three-dimensional structure, known as the inverse folding problem, is central to protein engineering but remains challenging due to the vast sequence space and the importance of local structural constraints. Existing deep learning approaches achieve strong recovery rates, yet they lack explicit mechanisms to reuse fine-grained structure-sequence patterns that are conserved across natural proteins. We present PRISM, a multimodal retrieval-augmented generation framework for inverse folding that retrieves fine-grained representations of potential motifs from known proteins and integrates them with a hybrid self-cross attention decoder. PRISM is formulated as a latent-variable probabilistic model and implemented with an efficient approximation, combining theoretical grounding with practical scalability. Across five benchmarks (CATH-4.2, TS50, TS500, CAMEO 2022, and the PDB date split), PRISM establishes new state of the art in both perplexity and amino acid recovery, while also improving foldability metrics (RMSD, TM-score, pLDDT), demonstrating that fine-grained multimodal retrieval is a powerful and efficient paradigm for protein sequence design.
Authors (3)
Sazan Mahbub
Souvik Kundu
Eric P. Xing
Submitted
October 12, 2025
arXiv Category
q-bio.QM
arXiv PDF

Key Contributions

Introduces PRISM, a retrieval-augmented generation framework for the inverse folding problem. It leverages fine-grained structure-sequence patterns from known proteins via retrieval and integrates them into a hybrid attention decoder. PRISM is formulated as a latent-variable probabilistic model, achieving new state-of-the-art results across multiple benchmarks by effectively reusing conserved motifs.

Business Value

Enables the rational design of novel proteins with specific functions, accelerating the development of new enzymes, therapeutics, biomaterials, and other protein-based technologies.